Apogee Therapeutics, Inc.
↗Waltham, USA
Apogee Therapeutics is a clinical-stage biotechnology company dedicated to developing optimized, novel biologics with the potential for best-in-class efficacy and dosing in the largest inflammatory and immunology (I&I) markets. The company leverages advanced antibody engineering to address significant unmet needs in conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma, and eosinophilic esophagitis (EoE).
Founded in 2022, Apogee focuses on overcoming the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties. The company is publicly traded on the NASDAQ and is headquartered in Waltham, Massachusetts.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Immunology and Inflammation
SIZE & FINANCIALS
Employees:201-500
Founded:2022
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Total Raised:$149M
Investors:RTW Investments, Deep Track Capital, Fairmount Funds Management, Venrock
STOCK
Exchange:NASDAQ
Ticker:APGE
Market Cap:$4.95B
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 2
Modalities:mAb
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Emerging
Competitors:BioNTech, ADMA Biologics, Nimbus Therapeutics
LEADERSHIP
Key Executives:
Michael Henderson - CEO
Carl Dambkowski - Chief Medical Officer
Jane Pritchett Henderson - Chief Financial Officer
Scientific Founders:Nimish Shah
Board Members:Mark C. McKenna, Lisa Bollinger, Jennifer Fox, Andrew Gottesdiener, Peter Harwin, BJ Jones, Tomas Kiselak
LINKS
Website:apogeetherapeutics.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Apogee Therapeutics, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Apogee Therapeutics, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.